PTC TherapeuticsvsUnitedHealth

PTCT and UNH stock compared: price, dividend, valuation and results, from SEC filings.

PTCT

PTC Therapeutics, Inc.

$56.42

Value $4.7B

-3.27%
PTCT's page

UNH

UnitedHealth Group Incorporated

$339.88

Value $309B

+2.85%
UNH's page

PTC Therapeutics (PTCT) has a market value of $4.7B and UnitedHealth (UNH) $309B. Over the last year, with dividends, PTCT moved -25.4% and UNH +12.9%. Dividend yield: PTCT none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PTCT$4.7B

    UNH$309B

    UNH is 66 times PTCT

  • Revenue, 12 months

    PTCT$1.2B

    UNH$450B

    UNH is 389 times PTCT

  • Net income, 12 months

    PTCT-$106M

    UNH$15.9B

  • Operating margin

    PTCT12.8%

    UNH5.3%

    7.5 points apart

  • ROIC

    PTCT27.8%

    UNH11.3%

    16.5 points apart

  • P/E

    PTCT–

    UNH19.4

  • Dividend yield

    PTCT0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    PTCT+41.0%

    UNH-15.4%

    56.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PTCT+41.0%

UNH-15.4%

5010015020020222023202420252026
Returns by period
PeriodPTCTWith dividendsUNHWith dividends
1 year since November 19, 2025-25.4%Price -25.4%+12.9%Price +10.0%
3 years since November 20, 2023+154.5%+36.5% a yearPrice +154.5%-32.4%-12.2% a yearPrice -36.5%
5 years since November 19, 2021+41.0%+7.1% a yearPrice +41.0%-15.4%-3.3% a yearPrice -22.8%
10 years since November 21, 2016+366.3%+16.6% a yearPrice +366.3%+166.8%+10.3% a yearPrice +126.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PTCTPTC TherapeuticsUNHUnitedHealth

Valuation

PTCTUNH
Valuation
Price$56.42$339.88
Market value$4.7B$309B
Enterprise value (EV)$3.1B$354B
P/E–19.4
P/E, 5-year median–25.0
P/B–3.0
EV/EBIT20.914.8
Free cash flow yield0.0%7.4%

Results and growth

PTCTUNH
Results and growth
Revenue, 12 months$1.2B$450B
Net income, 12 months-$106M$15.9B
Free cash flow, 12 months$2.1M$22.8B
Earnings per share, 12 months-$1.40$17.52
Revenue growth, year on year114.5%11.8%
Revenue growth a year, past+35.4%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

PTCTUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin12.8%5.3%
Net margin-9.2%3.5%
ROIC27.8%11.3%
ROE–15.5%

Balance sheet

PTCTUNH
Balance sheet
Cash$2.1B$28.5B
Total debt$636M$74.3B
Net debt / EBITDA-8.51.6
Interest cover–6.2×

Dividends and buybacks

PTCTUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PTCT or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, PTC Therapeutics or UnitedHealth?

By market value, UnitedHealth ($309B) is about 66.1 times PTC Therapeutics ($4.7B), at today's prices.

How did PTCT and UNH stock do over the last 10 years?

Since November 21, 2016, PTCT's price moved +366.3% and UNH's +126.0%. With dividends: PTCT +366.3% (+16.6% a year), UNH +166.8% (+10.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, PTCT or UNH?

The dividend yield at today's price is none for PTC Therapeutics and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, PTC Therapeutics or UnitedHealth?

Over the last twelve months, the net margin was -9.2% for PTC Therapeutics and 3.5% for UnitedHealth, and the operating margin 12.8% and 5.3%. Revenue was $1.2B and $450B.

Which is the better investment, PTC Therapeutics or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.